|
1
|
Cao SM, Simons MJ and Qian CN: The
prevalence and prevention of nasopharyngeal carcinoma in China.
Chin J Cancer. 30:114–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee AW, Ma BB, Ng WT and Chan AT:
Management of nasopharyngeal carcinoma: Current practice and future
perspective. J Clin Oncol. 33:3356–3364. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lun SW, Cheung ST, Cheung PF, To KF, Woo
JK, Choy KW, Chow C, Cheung CC, Chung GT, Cheng AS, et al:
CD44+ cancer stem-like cells in EBV-associated
nasopharyngeal carcinoma. PLoS One. 7:e524262012. View Article : Google Scholar
|
|
4
|
Zöller M: CD44: Can a cancer-initiating
cell profit from an abundantly expressed molecule? Nat Rev Cancer.
11:254–267. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takebe N, Miele L, Harris PJ, Jeong W,
Bando H, Kahn M, Yang SX and Ivy SP: Targeting Notch, Hedgehog, and
Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin
Oncol. 12:445–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garofalo M and Croce CM: Role of microRNAs
in maintaining cancer stem cells. Adv Drug Deliv Rev. 81:53–61.
2015. View Article : Google Scholar :
|
|
7
|
Wang ZM, Du WJ, Piazza GA and Xi Y:
MicroRNAs are involved in the self-renewal and differentiation of
cancer stem cells. Acta Pharmacol Sin. 34:1374–1380. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ravasio R, Ceccacci E and Minucci S:
Self-renewal of tumor cells: Epigenetic determinants of the cancer
stem cell phenotype. Curr Opin Genet Dev. 36:92–99. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Avgustinova A and Benitah SA: The
epigenetics of tumour initiation: Cancer stem cells and their
chromatin. Curr Opin Genet Dev. 36:8–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Muñoz P, Iliou MS and Esteller M:
Epigenetic alterations involved in cancer stem cell reprogramming.
Mol Oncol. 6:620–636. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chan KC, Chan LS, Ip JC, Lo C, Yip TT,
Ngan RK, Wong RN, Lo KW, Ng WT, Lee AW, et al: Therapeutic
targeting of CBP/β-catenin signaling reduces cancer stem-like
population and synergistically suppresses growth of EBV-positive
nasopharyngeal carcinoma cells with cisplatin. Sci Rep. 5:99792015.
View Article : Google Scholar
|
|
12
|
Busson P, Ganem G, Flores P, Mugneret F,
Clausse B, Caillou B, Braham K, Wakasugi H, Lipinski M and Tursz T:
Establishment and characterization of three transplantable
EBV-containing nasopharyngeal carcinomas. Int J Cancer. 42:599–606.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Glaser R, Zhang HY, Yao KT, Zhu HC, Wang
FX, Li GY, Wen DS and Li YP: Two epithelial tumor cell lines (HNE-1
and HONE-1) latently infected with Epstein-Barr virus that were
derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA.
86:9524–9528. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yao KT, Zhang HY, Zhu HC, Wang FX, Li GY,
Wen DS, Li YP, Tsai CH and Glaser R: Establishment and
characterization of two epithelial tumor cell lines (HNE-1 and
HONE-1) latently infected with Epstein-Barr virus and derived from
nasopharyngeal carcinomas. Int J Cancer. 45:83–89. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng Y, Ho RL, Chan KC, Kan R, Tung E,
Lung HL, Yau WL, Cheung AK, Ko JM, Zhang ZF, et al: Anti-angiogenic
pathway associations of the 3p21.3 mapped BLU gene in
nasopharyngeal carcinoma. Oncogene. 34:4219–4228. 2015. View Article : Google Scholar
|
|
16
|
Chai AW, Cheung AK, Dai W, Ko JM, Ip JC,
Chan KW, Kwong DL, Ng WT, Lee AW, Ngan RK, et al:
Metastasis-suppressing NID2, an epigenetically-silenced gene, in
the pathogenesis of nasopharyngeal carcinoma and esophageal
squamous cell carcinoma. Oncotarget. 7:78859–78871. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rahbari R, Sheahan T, Modes V, Collier P,
Macfarlane C and Badge RM: A novel L1 retrotransposon marker for
HeLa cell line identification. Biotechniques. 46:277–284. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peterson LF, Wang Y, Lo MC, Yan M, Kanbe E
and Zhang DE: The multi-functional cellular adhesion molecule CD44
is regulated by the 8;21 chromosomal translocation. Leukemia.
21:2010–2019. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lo MC, Yip TC, Ngan KC, Cheng WW, Law CK,
Chan PS, Chan KC, Wong CK, Wong RN, Lo KW, et al: Role of
MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma
tumor spheres. Cancer Lett. 335:81–92. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Wielenga VJ, Smits R, Korinek V, Smit L,
Kielman M, Fodde R, Clevers H and Pals ST: Expression of CD44 in
Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J
Pathol. 154:515–523. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bretscher A, Reczek D and Berryman M:
Ezrin: A protein requiring conformational activation to link
microfilaments to the plasma membrane in the assembly of cell
surface structures. J Cell Sci. 110:3011–3018. 1997.
|
|
23
|
Donatello S, Babina IS, Hazelwood LD, Hill
AD, Nabi IR and Hopkins AM: Lipid raft association restricts
CD44-ezrin interaction and promotion of breast cancer cell
migration. Am J Pathol. 181:2172–2187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang S, Mo Y, Midorikawa K, Zhang Z, Huang
G, Ma N, Zhao W, Hiraku Y, Oikawa S and Murata M: The potent tumor
suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal
carcinoma by targeting ANLN and HSPA4L. Oncotarget. 6:35893–35907.
2015.PubMed/NCBI
|
|
25
|
Strong MJ, Baddoo M, Nanbo A, Xu M,
Puetter A and Lin Z: Comprehensive high-throughput RNA sequencing
analysis reveals contamination of multiple nasopharyngeal carcinoma
cell lines with HeLa cell genomes. J Virol. 88:10696–10704. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Murphy JF, Lennon F, Steele C, Kelleher D,
Fitzgerald D and Long AC: Engagement of CD44 modulates
cyclooxygenase induction, VEGF generation, and proliferation in
human vascular endothelial cells. FASEB J. 19:446–448. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Subramaniam V, Vincent IR, Gilakjan M and
Jothy S: Suppression of human colon cancer tumors in nude mice by
siRNA CD44 gene therapy. Exp Mol Pathol. 83:332–340. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arpin M, Chirivino D, Naba A and
Zwaenepoel I: Emerging role for ERM proteins in cell adhesion and
migration. Cell Adhes Migr. 5:199–206. 2011. View Article : Google Scholar
|
|
29
|
Lin CH, Hung PH and Chen YJ: CD44 is
associated with the aggressive phenotype of nasopharyngeal
carcinoma through redox regulation. Int J Mol Sci. 14:13266–13281.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takahashi-Yanaga F and Kahn M: Targeting
Wnt signaling: Can we safely eradicate cancer stem cells? Clin
Cancer Res. 16:3153–3162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schmitt M, Metzger M, Gradl D, Davidson G
and Orian-Rousseau V: CD44 functions in Wnt signaling by regulating
LRP6 localization and activation. Cell Death Differ. 22:677–689.
2015. View Article : Google Scholar :
|
|
32
|
Li T, Chen JX, Fu XP, Yang S, Zhang Z,
Chen KhH and Li Y: microRNA expression profiling of nasopharyngeal
carcinoma. Oncol Rep. 25:1353–1363. 2011.PubMed/NCBI
|
|
33
|
Bao Y, Guo Y, Li Z, Fang W, Yang Y, Li X,
Li Z, Xiong B, Chen Z, Wang J, et al: MicroRNA profiling in Muc2
knockout mice of colitis-associated cancer model reveals epigenetic
alterations during chronic colitis malignant transformation. PLoS
One. 9:e991322014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Machová Poláková K, Lopotová T, Klamová H,
Burda P, Trněný M, Stopka T and Moravcová J: Expression patterns of
microRNAs associated with CML phases and their disease related
targets. Mol Cancer. 10:412011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Morris VA, Zhang A, Yang T, Stirewalt DL,
Ramamurthy R, Meshinchi S and Oehler VG: MicroRNA-150 expression
induces myeloid differentiation of human acute leukemia cells and
normal hematopoietic progenitors. PLoS One. 8:e758152013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao JJ, Lin J, Lwin T, Yang H, Guo J,
Kong W, Dessureault S, Moscinski LC, Rezania D, Dalton WS, et al:
microRNA expression profile and identification of miR-29 as a
prognostic marker and pathogenetic factor by targeting CDK6 in
mantle cell lymphoma. Blood. 115:2630–2639. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang M, Yang W, Li M and Li Y: Low
expression of miR-150 in pediatric intestinal Burkitt lymphoma. Exp
Mol Pathol. 96:261–266. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Assumpção MB, Moreira FC, Hamoy IG,
Magalhães L, Vidal A, Pereira A, Burbano R, Khayat A, Silva A,
Santos S, et al: High-throughput miRNA sequencing reveals a field
effect in gastric cancer and suggests an epigenetic network
mechanism. Bioinform Biol Insights. 9:111–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yokobori T, Suzuki S, Tanaka N, Inose T,
Sohda M, Sano A, Sakai M, Nakajima M, Miyazaki T, Kato H, et al:
miR-150 is associated with poor prognosis in esophageal squamous
cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci.
104:48–54. 2013. View Article : Google Scholar
|
|
40
|
Watanabe A, Tagawa H, Yamashita J, Teshima
K, Nara M, Iwamoto K, Kume M, Kameoka Y, Takahashi N, Nakagawa T,
et al: The role of microRNA-150 as a tumor suppressor in malignant
lymphoma. Leukemia. 25:1324–1334. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen S, Wang Z, Dai X, Pan J, Ge J, Han X,
Wu Z, Zhou X and Zhao T: Re-expression of microRNA-150 induces
EBV-positive Burkitt lymphoma differentiation by modulating c-Myb
in vitro. Cancer Sci. 104:826–834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jia Y, Ling M, Zhang L, Jiang S, Sha Y and
Zhao R: Downregulation of miR-150 expression by DNA
hypermeth-ylation is associated with high
2-hydroxy-(4-methylthio)butanoic acid-induced hepatic cholesterol
accumulation in nursery piglets. J Agric Food Chem. 64:7530–7539.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Endo K, Kondo S, Shackleford J, Horikawa
T, Kitagawa N, Yoshizaki T, Furukawa M, Zen Y and Pagano JS:
Phosphorylated ezrin is associated with EBV latent membrane protein
1 in naso-pharyngeal carcinoma and induces cell migration.
Oncogene. 28:1725–1735. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang L, Lin GN, Jiang XL and Lu Y:
Expression of ezrin correlates with poor prognosis of
nasopharyngeal carcinoma. Tumour Biol. 32:707–712. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tobo T, Hirahashi M, Yao T, Aishima S and
Oda Y: Ezrin expression and its phosphorylation in gastric
carcinoma with lymphoid stroma and Epstein-Barr virus infection.
Mol Clin Oncol. 1:220–224. 2013. View Article : Google Scholar
|
|
46
|
Teo JL and Kahn M: The Wnt signaling
pathway in cellular proliferation and differentiation: A tale of
two coactivators. Adv Drug Deliv Rev. 62:1149–1155. 2010.
View Article : Google Scholar : PubMed/NCBI
|
